Batch of anti-anxiety drug Xanax XR recalled nationwide in the United States

A batch of the anti-anxiety medication Xanax XR has been recalled across the United States.

The recall was issued by the Food and Drug Administration (FDA) due to safety concerns related to the affected pills.

The recalled Xanax XR pills were distributed and sold nationwide under the brand name.

The FDA has not specified the exact nature of the safety issues but has taken action to remove the batch from circulation.

No immediate reports of injuries or adverse effects have been confirmed in connection with the recall.

Authorities are advising patients and healthcare providers to check their medication and consult with medical professionals if they have concerns.

This recall is significant as Xanax XR is a widely prescribed medication for anxiety disorders, and any disruption in its availability or safety can impact public health and treatment continuity.

Xanax XR is an extended-release formulation commonly used to manage anxiety symptoms.

Recalls of such medications can affect pharmaceutical supply chains and patient confidence.

#XanaxXR #FDA #drugrecall #antianxietymedication #UnitedStates